Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
about
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gullsModulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis.Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers.Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccineReactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in childrenRelationship between surface antigens of two variants of influenza A (H3N2) virus, as revealed by hemagglutination inhibition, kinetic neutralization, and neuraminidase inhibition.Antigenic variation of influenza A virus nucleoprotein detected with monoclonal antibodiesEfficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity.Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China.Avian influenza virus (H11N9) in migratory shorebirds wintering in the Amazon Region, Brazil.Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).Matrix protein from influenza A virus and its role in cross-protection in mice.Coinfection of wild ducks by influenza A viruses: distribution patterns and biological significanceTemperature-sensitive mutants of influenza A virus: production and characterization of A/Victoria/3/75-ts-1[E] recombinants.Formation of antibody to matrix protein in experimental human influenza A virus infections.Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humansHeterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in miceProduction of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells.Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDRCharacterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2enCatalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin.Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses.The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infectionA study of acute respiratory disease in the community of Port Chalmers. II. Influenza A/Port Chalmers/1/73: intrafamilial spread and the effect of antibodies to the surface antigensComparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection.Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2)Use of single radial immunodiffusion test for serological studies in volunteers inoculated with live attenuated influenza virusA new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.Responses of volunteers to inactivated influenza virus vaccines.Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man.Influenza in the United Kingdom 1977-1981
P2860
Q24556678-A1EF3E55-1781-4F60-B087-C1B1116F4065Q30359683-3CF5282D-7E3A-41B4-A6FF-839816AF095CQ30377821-9A1ED11C-1D18-4E61-B9E4-438C725B5CA0Q30390818-C0D7DD84-9605-442F-8C53-1D59B9149B69Q30404512-88352B98-E6F4-482C-9978-7DB55F17135AQ30413824-340C74F6-CB64-46B1-964F-BCA316BB9C4EQ30425439-409BCC26-DE93-48FE-8408-FE12515CB80EQ33847234-43B22E0D-39E5-423C-B753-A43023562442Q33910623-9A3B6CF0-A025-4A9F-BCA4-731567FE8F97Q33921605-42E11C91-750F-4167-BB96-39A8766C82DFQ33981934-EAA05F65-1A1D-4DC7-BA4C-B95936BB5866Q34077963-00963987-5F09-4CC2-B233-81094A775A18Q34095297-8C4D3549-FF30-4DCB-89E7-4740D7D066C8Q34326581-DD4D1625-758D-485F-A9AB-5FB3119AC912Q34351902-665F3E1D-386F-4ED7-B4CD-551C398142D3Q34359863-4A3DD8A6-0C38-44E2-BB19-01D648EEC1B3Q34414335-77A7665F-6777-474B-8022-F6D6AB3CE8D0Q34432566-D1754CED-992E-489E-AB45-4E8A1823FF3FQ34447272-02BBC4B3-5F63-4EF1-905E-B79309C0CA20Q34459243-B802770B-DDBE-47C6-BCDF-6E970F6FA487Q34464574-F212FD36-DBFA-468E-8A06-10439B397A7DQ34971370-856D61D0-139B-4D36-97D6-19CAEA1E42F7Q35037680-0553FACE-2337-414D-813D-3E6ABA0E7C1CQ35097220-3A284C62-EBB3-4F65-9E80-0E8D70A444C4Q35857200-AACF7C83-625A-4811-85D9-80BD7587AF0EQ35882160-DAE14F13-9D3E-4C99-8017-87B09222A796Q35890376-D4CEC11E-5420-40DC-99A7-E7109647E65AQ36249554-9C2ADFD5-AB92-4520-92A5-4FBA36E28A50Q36249562-99565EF0-7973-4488-8254-19BD360553CDQ36249695-6E68E6A8-09EC-48CC-A804-2E04630F57A8Q36250689-815DEDF9-9657-4546-B582-6D6FE57FEEC1Q36250963-0BC812CD-2BFF-4093-BBC3-517D9691E36EQ36251063-502872FC-A2F9-4153-A0D5-9CF62F808E77Q36251132-B101A95E-0227-4DC6-B377-4ECAA11E8907Q36251711-167A3E3D-48D0-43E5-AEC4-34A9DC79D19FQ36251802-58308F2B-1A52-49B3-9634-33827E94484CQ36251811-FDA750DB-9709-4F12-9E0F-369370937B79Q36257974-654A9AD2-DBFA-4F24-81C8-E6E2E91A820AQ36258055-E4FA9418-3021-45B0-B6FE-5A819A35D190Q36258102-EF632689-39EC-4BFF-83F3-F1DEC264B9A0
P2860
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
@en
type
label
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
@en
prefLabel
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
@en
P2093
P2860
P1476
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
@en
P2093
Aymard-Henry M
Coleman MT
Webster RG
P2860
P304
P407
P577
1973-01-01T00:00:00Z